FI880163A - Förfarande för framställning av en lösning som kan användas som läkemedel - Google Patents

Förfarande för framställning av en lösning som kan användas som läkemedel Download PDF

Info

Publication number
FI880163A
FI880163A FI880163A FI880163A FI880163A FI 880163 A FI880163 A FI 880163A FI 880163 A FI880163 A FI 880163A FI 880163 A FI880163 A FI 880163A FI 880163 A FI880163 A FI 880163A
Authority
FI
Finland
Prior art keywords
c2h4o
medicament
preparing
solution
c3h6o
Prior art date
Application number
FI880163A
Other languages
English (en)
Finnish (fi)
Other versions
FI94928C (sv
FI880163A0 (sv
FI94928B (sv
Inventor
Robert L Hunter
Alexander Duncan
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/045,459 external-priority patent/US4801452A/en
Application filed by Univ Emory filed Critical Univ Emory
Publication of FI880163A publication Critical patent/FI880163A/sv
Publication of FI880163A0 publication Critical patent/FI880163A0/sv
Application granted granted Critical
Publication of FI94928B publication Critical patent/FI94928B/sv
Publication of FI94928C publication Critical patent/FI94928C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Neurology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI880163A 1986-05-15 1988-01-14 Förfarande för framställning av en lösning som kan användas som läkemedel FI94928C (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US86358286A 1986-05-15 1986-05-15
US86358286 1986-05-15
US4388887A 1987-04-29 1987-04-29
US4388887 1987-04-29
US07/045,459 US4801452A (en) 1986-05-15 1987-05-07 Fibrinolytic composition
US4545987 1987-05-07
PCT/US1987/001067 WO1987006836A1 (en) 1986-05-15 1987-05-08 Fibrinolytic composition
US8701067 1987-05-08

Publications (4)

Publication Number Publication Date
FI880163A true FI880163A (sv) 1988-01-14
FI880163A0 FI880163A0 (sv) 1988-01-14
FI94928B FI94928B (sv) 1995-08-15
FI94928C FI94928C (sv) 1995-11-27

Family

ID=27366409

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880163A FI94928C (sv) 1986-05-15 1988-01-14 Förfarande för framställning av en lösning som kan användas som läkemedel

Country Status (11)

Country Link
EP (3) EP0498470B1 (sv)
JP (9) JPH0610139B2 (sv)
KR (1) KR880701107A (sv)
AT (1) ATE142502T1 (sv)
AU (1) AU599392B2 (sv)
BR (1) BR8707308A (sv)
DE (2) DE3751907T2 (sv)
DK (1) DK10888A (sv)
FI (1) FI94928C (sv)
IL (1) IL82519A (sv)
WO (1) WO1987006836A1 (sv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.
US5039520A (en) * 1986-05-15 1991-08-13 Emory University Plasma extender
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
JPH0610139B2 (ja) * 1986-05-15 1994-02-09 エモリ ユニバーシティ 繊維素溶解性合成物混合物及び血管内の血餅溶解用薬剤
US5648071A (en) * 1986-05-15 1997-07-15 Emory University Method of treating tumors
US5182106A (en) * 1986-05-15 1993-01-26 Emory University Method for treating hypothermia
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
KR100194113B1 (ko) * 1988-04-04 1999-06-15 어니스트 엠. 해데드 혈병 용해 촉진 조성물
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
AU635541B2 (en) * 1989-05-17 1993-03-25 Research Corporation Technologies, Inc. Method and composition for the treatment of thrombosis in a mammal
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US5696298A (en) * 1991-03-19 1997-12-09 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
AU662146B2 (en) * 1991-03-19 1995-08-24 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US5470568A (en) * 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
US5605687A (en) * 1992-05-15 1997-02-25 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for repair of electrical injury
GB2289069B (en) * 1994-03-31 1997-12-17 Toppan Moore Kk Microcapsule-containing oil-based coating liquid,ink,coated sheet,and method of prepring the same
WO1995033474A1 (fr) * 1994-06-03 1995-12-14 Tsumura & Co. Composition medicinale
KR100241202B1 (ko) * 1995-09-12 2000-02-01 니시무로 타이죠 전류미러회로
EP0937146A2 (en) * 1996-09-20 1999-08-25 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
CA2420182A1 (en) * 2000-08-25 2002-03-07 Organ Recovery Systems, Inc. Methods of thrombolytic organ treatment and repair
DE10314083A1 (de) * 2003-03-28 2004-10-14 Mcs Micro Carrier Systems Gmbh Produkt zum Schutz von Blutgefäßen
JPWO2006035673A1 (ja) * 2004-09-28 2008-05-15 独立行政法人科学技術振興機構 虚血性心臓傷害の新保護法
US8211817B2 (en) 2006-09-11 2012-07-03 Tosoh Corporation Fused silica glass and process for producing the same
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン
ES2728480T3 (es) * 2012-09-08 2019-10-24 Organ Technologies Inc Método para mantener un órgano o tejido para su uso para trasplante durante un largo período
TWI688392B (zh) * 2014-07-07 2020-03-21 美商救生筏生物科技公司 無長循環材料之泊洛沙姆組成物以及其製造方法和用途
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
US20190104718A1 (en) * 2017-10-09 2019-04-11 Efran Cano Entry barrier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
US3980772A (en) * 1969-12-02 1976-09-14 Baxter Laboratories, Inc. Methods of dissolving blood clots and the like with streptokinase chemically bonded to a carbohydrate matrix
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4186253A (en) * 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
EP0098110B1 (en) * 1982-06-24 1989-10-18 NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD Long-acting composition
JPS5959629A (ja) * 1982-09-27 1984-04-05 Nippon Chem Res Kk 効力持続性組成物
JPS61176532A (ja) * 1985-01-30 1986-08-08 Green Cross Corp:The プラスミノ−ゲンアクチベ−タ−前駆体の安定化方法
JPH0610139B2 (ja) * 1986-05-15 1994-02-09 エモリ ユニバーシティ 繊維素溶解性合成物混合物及び血管内の血餅溶解用薬剤

Also Published As

Publication number Publication date
FI94928C (sv) 1995-11-27
JPH0616562A (ja) 1994-01-25
EP0266419A1 (en) 1988-05-11
DE3751907D1 (de) 1996-10-17
EP0451880A2 (en) 1991-10-16
DK10888A (da) 1988-03-11
DE3789196T2 (de) 1994-06-16
DE3789196D1 (de) 1994-04-07
EP0451880A3 (en) 1991-12-27
DE3751907T2 (de) 1997-04-03
JPH0648951A (ja) 1994-02-22
JPH0757730B2 (ja) 1995-06-21
EP0266419A4 (en) 1989-03-15
JPH0610139B2 (ja) 1994-02-09
AU599392B2 (en) 1990-07-19
JPH0624993A (ja) 1994-02-01
EP0498470A2 (en) 1992-08-12
EP0266419B1 (en) 1994-03-02
JPH0616567A (ja) 1994-01-25
JPH0616565A (ja) 1994-01-25
EP0498470A3 (en) 1993-03-03
JPH0653685B2 (ja) 1994-07-20
KR880701107A (ko) 1988-07-25
JPH0640924A (ja) 1994-02-15
ATE142502T1 (de) 1996-09-15
BR8707308A (pt) 1988-09-13
DK10888D0 (da) 1988-01-11
FI880163A0 (sv) 1988-01-14
FI94928B (sv) 1995-08-15
AU7484087A (en) 1987-12-01
JPH06100454A (ja) 1994-04-12
WO1987006836A1 (en) 1987-11-19
IL82519A (en) 1992-05-25
JPH0616571A (ja) 1994-01-25
JPH01500592A (ja) 1989-03-01
JPH0735337B2 (ja) 1995-04-19
JPH0735336B2 (ja) 1995-04-19
EP0498470B1 (en) 1996-09-11
JPH0735338B2 (ja) 1995-04-19

Similar Documents

Publication Publication Date Title
FI880163A (sv) Förfarande för framställning av en lösning som kan användas som läkemedel
PT96289A (pt) Processamento para a preparacao de composicoes farmaceuticas para o trtamento de infeccoes virais
ATE152610T1 (de) Durchsichtige kosmetikstifte
ATE152113T1 (de) Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
BR1100445A (pt) Derivados imino cìclicos, composições farmacêuticas contendo estes compostos e processo para sua preparação
ATE188219T1 (de) Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
JPS5663923A (en) Suppository base composition
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
DE3773440D1 (de) Pharmazeutische zusammensetzungen fuer suppositorien.
DK0506772T3 (da) Farmaceutisk præparat indeholdende et phosphosukker
OA09119A (fr) Nouveaux céphèmes et leur préparation.
SE8600658D0 (sv) Novel composition of matter
SE7503952L (sv) Sett att framstella spasmolytiska foreningar.
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
FR2409996A1 (fr) 15-epi-prostacycline et analogues, utiles notamment comme agents antithrombotiques et thrombolytiques et leur procede de preparation
ATE179071T1 (de) Verwendung eines thioesters zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischämie und von reperfusion-syndromen
GB1424432A (en) Pharmaceutical compositions
GB1508338A (en) Pharmaceutical compositions
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
KR960703924A (ko) 항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents)
KR920006354A (ko) 피라졸로퀴놀린 유도체
GB976217A (en) Improvements in or relating to novel substituted phenothiazines
HUT59597A (en) Process for producing pharmaceutical compositions contaiing pharmaceutically active tetrahydro-naphtalene derivatives
KR890003678A (ko) 부정맥 치료제
ES464250A1 (es) Procedimiento de preparacion de nuevos esteres del acido isobutirico disustituido.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: EMORY UNIVERSITY